Induction of Cross-reactive Antibodies to Novel H7N9 Influenza Virus by Recombinant Newcastle Disease Virus Expressing a North American Lineage H7 Subtype Hemagglutinin

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2013 May 24

PMID 23698299

Citations 38

Authors

Peter H Goff

Florian Krammer

Rong Hai

Christopher W Seibert

Irina Margine

Adolfo Garcia-Sastre

Peter Palese

Affiliations

Soon will be listed here.

Abstract

Severe human disease caused by the emerging H7N9 influenza virus in China warrants a rapid response. Here, we present a recombinant Newcastle disease virus expressing a North American lineage H7 influenza virus hemagglutinin. Sera from immunized mice were cross-reactive to a broad range of H7 subtype viruses and inhibited hemagglutination by the novel H7 hemagglutinin. Immunized mice were protected against a heterologous H7 subtype challenge, and genetic analysis suggested that cross-protective antibodies recognize conserved antigenic sites.

Citing Articles

Immunity and Protective Efficacy of a Plant-Based Tobacco Mosaic Virus-like Nanoparticle Vaccine against Influenza a Virus in Mice.

Madapong A, Petro-Turnquist E, Webby R, McCormick A, Weaver E Vaccines (Basel). 2024; 12(10).

PMID: 39460267 PMC: 11510914. DOI: 10.3390/vaccines12101100.

Delivery of Fc-fusion Protein by a Recombinant Newcastle Disease Virus Vector.

Hu Z, Feng J, Deng J, Zhang Y, He X, Hu J Appl Biochem Biotechnol. 2022; 195(3):2077-2092.

PMID: 36417109 DOI: 10.1007/s12010-022-04237-4.

Evolution of the North American Lineage H7 Avian Influenza Viruses in Association with H7 Virus's Introduction to Poultry.

Youk S, Leyson C, Killian M, Torchetti M, Lee D, Suarez D J Virol. 2022; 96(14):e0027822.

PMID: 35862690 PMC: 9327676. DOI: 10.1128/jvi.00278-22.

Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use.

Fulber J, Kamen A Viruses. 2022; 14(5).

PMID: 35632717 PMC: 9143368. DOI: 10.3390/v14050975.

Avian Orthoavulavirus Type-1 as Vaccine Vector against Respiratory Viral Pathogens in Animal and Human.

Vilela J, Rohaim M, Munir M Vaccines (Basel). 2022; 10(2).

PMID: 35214716 PMC: 8876055. DOI: 10.3390/vaccines10020259.

References

Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W . Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013; 368(20):1888-97. DOI: 10.1056/NEJMoa1304459. View

Goff P, Gao Q, Palese P . A majority of infectious Newcastle disease virus particles contain a single genome, while a minority contain multiple genomes. J Virol. 2012; 86(19):10852-6. PMC: 3457277. DOI: 10.1128/JVI.01298-12. View

Skowronski D, Li Y, Tweed S, Tam T, Petric M, David S . Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ. 2007; 176(1):47-53. PMC: 1764568. DOI: 10.1503/cmaj.060204. View

Whiteley A, Major D, Legastelois I, Campitelli L, Donatelli I, Thompson C . Generation of candidate human influenza vaccine strains in cell culture - rehearsing the European response to an H7N1 pandemic threat. Influenza Other Respir Viruses. 2009; 1(4):157-66. PMC: 4634536. DOI: 10.1111/j.1750-2659.2007.00022.x. View

Krammer F, Pica N, Hai R, Margine I, Palese P . Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J Virol. 2013; 87(12):6542-50. PMC: 3676110. DOI: 10.1128/JVI.00641-13. View

Belser J, Davis C, Balish A, Edwards L, Zeng H, Maines T . Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis. J Virol. 2013; 87(10):5746-54. PMC: 3648195. DOI: 10.1128/JVI.00154-13. View

Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H . Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet. 2004; 363(9409):587-93. DOI: 10.1016/S0140-6736(04)15589-X. View

Ekiert D, Wilson I . Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. Curr Opin Virol. 2012; 2(2):134-41. PMC: 3368890. DOI: 10.1016/j.coviro.2012.02.005. View

Hai R, Krammer F, Tan G, Pica N, Eggink D, Maamary J . Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J Virol. 2012; 86(10):5774-81. PMC: 3347257. DOI: 10.1128/JVI.00137-12. View

10.

Chen H, Bu Z . Development and application of avian influenza vaccines in China. Curr Top Microbiol Immunol. 2009; 333:153-62. DOI: 10.1007/978-3-540-92165-3_7. View

11.

Talaat K, Karron R, Callahan K, Luke C, DiLorenzo S, Chen G . A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine. 2009; 27(28):3744-53. PMC: 2771405. DOI: 10.1016/j.vaccine.2009.03.082. View

12.

Cox R, Madhun A, Hauge S, Sjursen H, Major D, Kuhne M . A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Vaccine. 2009; 27(13):1889-97. DOI: 10.1016/j.vaccine.2009.01.116. View

13.

Fouchier R, Schneeberger P, Rozendaal F, Broekman J, Kemink S, Munster V . Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A. 2004; 101(5):1356-61. PMC: 337057. DOI: 10.1073/pnas.0308352100. View

14.

Min J, Vogel L, Matsuoka Y, Lu B, Swayne D, Jin H . A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. J Virol. 2010; 84(22):11950-60. PMC: 2977864. DOI: 10.1128/JVI.01305-10. View

15.

Runstadler J, Hill N, Hussein I, Puryear W, Keogh M . Connecting the study of wild influenza with the potential for pandemic disease. Infect Genet Evol. 2013; 17:162-87. PMC: 3685205. DOI: 10.1016/j.meegid.2013.02.020. View

16.

Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, Uchida Y . Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill. 2013; 18(15):20453. PMC: 6296756. View

17.

Park M, Steel J, Garcia-Sastre A, Swayne D, Palese P . Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A. 2006; 103(21):8203-8. PMC: 1464378. DOI: 10.1073/pnas.0602566103. View

18.

Marangon S, Cecchinato M, Capua I . Use of vaccination in avian influenza control and eradication. Zoonoses Public Health. 2008; 55(1):65-72. DOI: 10.1111/j.1863-2378.2007.01086.x. View

19.

Abbas M, Spackman E, Fouchier R, Smith D, Ahmed Z, Siddique N . H7 avian influenza virus vaccines protect chickens against challenge with antigenically diverse isolates. Vaccine. 2011; 29(43):7424-9. DOI: 10.1016/j.vaccine.2011.07.064. View

20.

Lina B, Bouscambert M, Enouf V, Rousset D, Valette M, van der Werf S . S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses. Euro Surveill. 2012; 16(50):20039. View